|
|
|
| Clinical effect of endobronchial tube pump in the treatment of thick-wall cavity pulmonary tuberculosis |
| JIANG Lin LU Feiyan ZHOU Jing PENG Pinghua LAI Haibin ZENG Zhong |
| Department of Tuberculosis, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Disease Prevention and Control, the Fifth People's Hospital of Ganzhou, Jiangxi Province, Ganzhou 341000, China |
|
|
|
|
Abstract Objective To explore the clinical effect of endobronchial tube pump in the treatment of thick-wall cavity pulmonary tuberculosis. Methods A total of 60 patients with thick-wall cavity pulmonary tuberculosis admitted to the Fifth People's Hospital of Ganzhou from October 2019 to December 2020 were selected as the study objects, and they were divided into observation group and control group according to lottery method, with 30 cases in each group. The control group was treated with conventional antituberculosis chemotherapy, and the observation group was treated with endobronchial tube pump on the basis of conventional antituberculosis. The negative conversion rate of sputum tuberculosis, cavity closure rate, recurrence rate and adverse reactions were compared between the two groups. Results There was no statistically significant difference in the negative conversion rate of sputum tuberculosis between the two groups after 1 month of treatment (P＞0.05). After 2 months of treatment, the negative conversion rate of sputum tuberculosis in the observation group was higher than that in the control group, and the difference was statistically significant (P＜0.05). After 6 months of treatment, the sputum tuberculosis in the two groups turned negative, and the difference was not statistically significant (P＞0.05). After 1 month of treatment, there was no statistically significant difference in the cavity closure rate between the two groups (P＞0.05). After 2 and 6 months of treatment, the cavity closure rates of the observation group were 90.00% and 93.33%, which were higher than 43.33% and 56.67% of the control group, and the differences were statistically significant (P＜0.05). After 1 year of follow-up, there was no significant difference in the recurrence rate of thick-walled cavitary tuberculosis between the two groups (P＞0.05). There was no statistically significant difference in the total incidence of adverse reaction between the two groups (P＞0.05). Conclusion The effect of endobronchial tube pump drug in the treatment of thick-wall cavitary pulmonary tuberculosis is significant, which can promote the sputum to find tuberculosis bacteria to turn negative, improve the cavity closure rate, the recurrence rate is low, and there is no obvious adverse reaction.
|
|
|
|
|
|
| [1] |
刘永桃，海杰，贺成彦.手术联合抗结核药物治疗空洞性肺结核的疗效及对IL-8，TNF-α等细胞因子的影响[J].临床和实验医学杂志，2020，19（22）：2431-2434.
|
| [2] |
罗莉，卢志斌，肖阳宝，等.超细支气管镜在空洞型肺结核合并气管支气管结核诊断中的应用[J].临床肺科杂志，2019，24（3）：534-537.
|
| [3] |
史海霞，聂素军，杨瑞波，等.经支气管镜辅助灌注药物治疗难治性空洞型肺结核效果观察[J].山西医药杂志，2020，49（20）：2735-2737.
|
| [4] |
宋巍峰.内消瘰疬丸配合CT引导下经皮肺穿刺给药治疗耐多药空洞型肺结核疗效及其机制[J].现代中西医结合杂志，2019，28（27）：3024-3028.
|
| [5] |
沈剑，卢芳，李吉.纤维支气管镜下介入治疗肺结核的护理干预措施的临床效果[J].沈阳药科大学学报，2021，38（2）：78．
|
| [6] |
赖宏智，李史来，陈伟生，等.经纤维支气管镜局部灌注抗结核药物辅助治疗空洞性肺结核的临床观察[J].中国防痨杂志，2017，39（3）：252-255.
|
| [7] |
蔡晓静.经支气管镜局部药物注射合化疗治疗耐多药肺结核的临床观察[J].实用中西医结合临床，2022，22（24）：39-41.
|
| [8] |
陈良忠，朱大庆.赣州市肺结核患者住院期间获得性肺部多药耐药菌感染情况及其影响因素分析[J].当代医学，2022，28（16）：166-169.
|
| [9] |
谭新良.纤维支气管镜下给药治疗耐多药空洞型肺结核的效果[J].临床医学，2022，42（6）：57-59.
|
| [10] |
谢贵娟.异烟肼联合阿米卡星支气管镜下注药对耐多药肺结核患者临床效果及免疫功能的影响[J].反射疗法与康复医学，2022，3（4）：75-77.
|
| [11] |
古丽巴哈尔·阿不拉合买提，玛依拉·卡德尔，卡力曼·阿不都热合曼，等.支气管镜介入治疗肺结核合并支气管结核老年患者的病灶吸收率和安全性[J].中国内镜杂志，2021，27（9）：69-74.
|
| [12] |
戴粹新.耐多药肺结核伴空洞患者CT影像特征分析及诊断价值[J].现代诊断与治疗，2022，33（15）：2310-2313.
|
| [13] |
付红继，杜凤玲.经支气管镜辅助灌注药物治疗难治性空洞型肺结核的临床效果[J].临床医学研究与实践，2021，6（36）：82-84.
|
| [14] |
高华，石海萍，张权武，等.康复新液辅助纤维支气管镜灌注联合化疗对耐多药肺结核患者肺功能，炎症因子和T淋巴细胞亚群的影响[J].现代生物医学进展，2020，20（21）：4147-4151.
|
| [15] |
翁加豪，陈伟生，杨仪，等.纤维支气管镜下给药治疗耐多药空洞型肺结核疗效研究[J].广州医药，2020，51（2）：65-67.
|
| [16] |
任晓霞.经纤维支气管镜局部灌注给药治疗空洞性肺结核效果观察[J].医药前沿，2019，9（28）：97-98.
|
| [17] |
孙晓婷.复治涂阳空洞型肺结核应用支气管镜下药物注射联合康复新液的疗效分析[J].当代医学，2020，26（5）：140-141.
|
| [18] |
蒙是升，龙妍帆.纤维支气管镜介入联合雾化吸入治疗空洞型肺结核合并支气管结核的疗效分析[J].现代医学与健康研究电子杂志，2022，6（19）：60-63.
|
| [19] |
赵欣.涂片阳性初治失败空洞型肺结核采用左氧氟沙星经纤维支气管镜介入灌注治疗的疗效[J].当代医学，2019，25（30）：93-95.
|
| [20] |
董振力.经纤维支气管镜局部注射辅助治疗耐多药肺结核对T淋巴细胞亚群的影响[J].北方药学，2019，16（5）：112-113.
|
| [21] |
杜佳辉，张光照，袁五营，等.双镜联合精准肺叶/段切除术在耐多药空洞型肺结核治疗中的临床应用研究[J].锦州医科大学学报，2022，43（6）：66-71.
|
| [22] |
李茂英，刘海燕，李曦.声动力靶位药物传输联合HRZES方案治疗复治空洞型肺结核的疗效研究[J].蚌埠医学院学报，2021，46（10）：1432-1434.
|
| [23] |
冯丽静，丁艳芳.继发性肺结核合并支气管结核患者采用抗结核药物联合雾化吸入治疗痰菌阴转率与疗效分析[J].数理医药学杂志，2020，33（5）：726-727.
|
|
|
|
